Victor E Yushmanov
Overview
Explore the profile of Victor E Yushmanov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
169
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mayeli A, Sonnenschein S, Yushmanov V, Wilson J, Blazer A, Foran W, et al.
Int J Mol Sci
. 2022 Dec;
23(24).
PMID: 36555487
Converging lines of evidence suggest that an imbalance between excitation and inhibition is present in the dorsolateral prefrontal cortex (DLPFC) of schizophrenia (SCZ). Gamma-aminobutyric-acid (GABA) and, to a lesser extent,...
2.
Perica M, Calabro F, Larsen B, Foran W, Yushmanov V, Hetherington H, et al.
Prog Neurobiol
. 2022 Oct;
219:102370.
PMID: 36309210
Animal and human postmortem studies provide evidence for changes in gamma-aminobutyric acid (GABA) and glutamate in prefrontal cortex (PFC) during adolescence, suggesting shifts in excitation and inhibition balance consistent with...
3.
Sonnenschein S, Mayeli A, Yushmanov V, Blazer A, Calabro F, Perica M, et al.
Schizophr Res
. 2022 Aug;
248:98-106.
PMID: 36029656
Individuals with first-episode schizophrenia (FES) typically present with acute psychotic symptoms. Though antipsychotic drugs are the mainstay for treatment, the neurobiology underlying successful treatment remains largely elusive. Recent evidence from...
4.
Quinones G, Mayeli A, Yushmanov V, Hetherington H, Ferrarelli F
Neuropsychopharmacology
. 2020 Dec;
46(6):1133-1139.
PMID: 33273706
Youth at clinical high risk (CHR) are a unique population enriched for precursors of major psychiatric disorders, especially schizophrenia (SCZ). Recent neuroimaging findings point to abnormalities in the thalamus of...
5.
Schirda C, Zhao T, Yushmanov V, Lee Y, Ghearing G, Lieberman F, et al.
Magn Reson Med
. 2017 Sep;
79(5):2470-2480.
PMID: 28905419
Purpose: To use a fast 3D rosette spectroscopic imaging acquisition to quantitatively evaluate how spectral quality influences detection of the endogenous variation of gray and white matter metabolite differences in...
6.
Yushmanov V, Kharlamov A, Yanovski B, LaVerde G, Boada F, Jones S
Brain Res
. 2013 Jun;
1527:199-208.
PMID: 23792152
This study addresses the spatial relation between local Na(+) and K(+) imbalances in the ischemic core in a rat model of focal ischemic stroke. Quantitative [Na(+)] and [K(+)] brain maps...
7.
Yushmanov V, Kharlamov A, Ibrahim T, Zhao T, Boada F, Jones S
NMR Biomed
. 2011 Aug;
24(7):778-83.
PMID: 21834001
The aims of the present study were as follows: (i) to perform the first (87)Rb MRI in live rats with focal ischemic stroke; and (ii) to test the hypothesis that...
8.
Yushmanov V, Kharlamov A, Yanovski B, LaVerde G, Boada F, Jones S
J Magn Reson Imaging
. 2009 Jun;
30(1):18-24.
PMID: 19557842
Purpose: To test the hypotheses that (i) the regional heterogeneity of brain sodium concentration ([Na(+)](br)) provides a parameter for ischemic progression not available from apparent diffusion coefficient (ADC) data, and...
9.
Kharlamov A, LaVerde G, Nemoto E, Jungreis C, Yushmanov V, Jones S, et al.
J Neurosci Methods
. 2009 Jun;
182(2):205-10.
PMID: 19540877
The delineation of early infarction in large gyrencephalic brain cannot be accomplished with triphenyl-tetrazolium chloride (TTC) due to its limitations in the early phase, nor can it be identified with...
10.
Yushmanov V, Yanovski B, Kharlamov A, LaVerde G, Boada F, Jones S
J Magn Reson Imaging
. 2009 Mar;
29(4):962-6.
PMID: 19306443
Purpose: To validate (23)Na twisted projection magnetic resonance imaging (MRI) as a quantitative technique to assess local brain sodium concentration ([Na(+)](br)) during rat focal ischemia every 5.3 minutes. Materials And...